DOTAP Workflows for Nucleic Acid Delivery
2026-08-20
DOTAP offers a controllable route to complex DNA, RNA, and antisense oligonucleotides for transient expression, gene silencing, and lipid nanoparticle optimization. This guide connects practical transfection design with the immune-metabolic logic of a recent nano-granulated zoledronate study while clearly separating established evidence from formulation recommendations.
Nebivolol Hydrochloride: Reading Negative TOR Data
2026-08-20
Nebivolol hydrochloride is a potent β1-adrenoceptor antagonist for receptor-focused cardiovascular studies. This article explains how a 2025 drug-sensitized yeast study places its negative TOR result in the correct assay and mechanistic context.
LLC-PK1-MDR1 Model for BBB Permeability
2026-08-19
Hu and colleagues developed a Transwell surrogate blood–brain barrier model that combines LLC-PK1-MOCK/MDR1 cells with permeability, efflux, and recovery measurements. Its key advance is the use of bafilomycin A1 to correct lysosomal trapping, improving the relationship between in vitro transport data and in vivo unbound brain distribution.
Bazedoxifene and IL-6/GP130 Signaling in Cancer
2026-08-19
The 2024 review by Shi and colleagues examines Bazedoxifene, a selective estrogen receptor modulator, as a repurposing candidate that may inhibit oncogenic IL-6/GP130 signaling. Its key contribution is to connect structure-guided drug repositioning with evidence from cancer models, while identifying the mechanistic and translational questions that must be resolved before oncology trials.
Methylprednisolone in Bone Remodeling Assays
2026-08-18
Methylprednisolone is more than a glucocorticoid exposure reagent: it can serve as a controlled perturbation for connecting inflammatory signaling, osteoclast activity, and tissue-level bone injury. This article translates a rat osteonecrosis study into practical assay-design decisions while addressing model interpretation, formulation, and translational limits.
Angiotensin II: From Pressure Signal to Heart Failure
2026-08-18
Angiotensin II is more than a vasopressor challenge: it is a versatile translational perturbation linking GPCR signaling, vascular remodeling, cardiomyocyte stress, and macrophage interferon biology. This article translates recent Mertk–IFN-β findings into practical model-selection, validation, and workflow strategies.
PUFA-PL Enzymes in Rice Blast Pathogenicity
2026-08-17
The 2024 Mycology study links Magnaporthe oryzae pathogenicity to Fad2- and Acsl4-dependent production of polyunsaturated fatty acid phospholipids and ferroptosis-associated lipid peroxidation. Genetic analysis, targeted lipidomics, iron-mediated rescue, and interaction studies together identify PUFA-PL metabolism as a potential disease-control target, while also defining important limits on causal interpretation.
CHIR 99021 Trihydrochloride in Organoids
2026-08-16
CHIR 99021 trihydrochloride is a selective GSK-3 inhibitor for probing the balance between organoid self-renewal, proliferation, and lineage diversification. This article connects its molecular action to practical assay design, metabolic disease modeling, and the key insights of a tunable human intestinal organoid study.
Superoxide Dismutase (SOD) Activity Assay Kit
2026-08-15
The Superoxide Dismutase (SOD) Activity Assay Kit K2035 provides a rapid colorimetric method for measuring SOD activity in biological fluids through XO-driven WST-1 reduction at 450 nm. It is suited to research workflows such as oxidative stress assay, antioxidative enzyme assay, and cancer research, but it does not directly measure hydrogen peroxide, total reactive oxygen species, or clinical status.
Coumestrol: Designing Mechanism-Resolved Assays
2026-08-15
Coumestrol is a phytoestrogen estrogen receptor antagonist with a distinctive concentration-dependent nuclear receptor and ferroptosis research profile. This guide shows how to separate estrogen receptor signaling pathway effects from PMAIP1-linked ferroptosis in rheumatoid arthritis synoviocyte assays.
SEMA3E, β-Catenin, and Beige Fat Thermogenesis
2026-08-14
A 2026 mouse study identifies the secreted semaphorin SEMA3E as a regulator of beige adipocyte differentiation and non-shivering thermogenesis in inguinal white adipose tissue. Through gain- and loss-of-function experiments, mitochondrial respiration analyses, RNA sequencing, and pathway rescue, the work connects SEMA3E to β-catenin signaling and thermogenic remodeling.
L-Phenylephrine in Adrenergic α1A Assays
2026-08-14
Build more interpretable α1A receptor experiments with L-Phenylephrine across vascular, cardiac, neural, and baroreflex models. This guide translates sex-aware hypertension findings into practical dose-response design, controls, workflow parameters, and troubleshooting strategies.
MMP-2-Responsive Liposomes for Sequential Immunotherapy
2026-08-13
The reference study developed NLG919@Lip-pep1, an MMP-2-responsive liposome designed to deliver the PD-1 pathway blockade peptide AUNP-12 before exposing a secondary tumor-targeting module carrying the IDO inhibitor NLG919. In breast cancer models, this cascade-oriented design was reported to improve immune activation and remodel immunosuppressive tumor biology more effectively than uncoordinated single-agent treatment.
NSC 87877 Shp2 Inhibitor Workflow Guide
2026-08-13
Use NSC 87877 to separate SHP2-dependent signaling from upstream receptor events in microglial, cancer, and inflammatory pain models. This workflow translates the Nespas/miR-383-3p/SHP2 findings after ischemic stroke into practical pharmacology, controls, and troubleshooting decisions.
AL-8810: Prostaglandin F2α Antagonist
2026-08-12
AL-8810 is a prostaglandin F2α antagonist that selectively targets the FP receptor for mechanistic cell and tissue research. Product benchmarks and a peer-reviewed mouse menstrual-like model support its use in studying FP receptor signaling, vascular dynamics, smooth muscle responses, and endometrial breakdown.
462 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page